Ralaniten Sensitizes Enzalutamide-Resistant Prostate Cancer to Ionizing Radiation in Prostate Cancer Cells that Express Androgen Receptor Splice Variants
Carmen A. Bañuelos(BC Cancer Agency), Marianne D. Sadar(BC Cancer Agency)
Cited by 32
Related Papers
Activation of the Androgen Receptor N-terminal Domain by Interleukin-6 via MAPK and STAT3 Signal Transduction Pathways
|Journal of Biological Chemistry|2002|381
An androgen receptor N-terminal domain antagonist for treating prostate cancer
|Journal of Clinical Investigation|2013|310
Ligand-independent Activation of the Androgen Receptor by Interleukin-6 and the Role of Steroid Receptor Coactivator-1 in Prostate Cancer Cells
|Journal of Biological Chemistry|2002|304
Sintokamide A Is a Novel Antagonist of Androgen Receptor That Uniquely Binds Activation Function-1 in Its Amino-terminal Domain
|Journal of Biological Chemistry|2016|59